100 related articles for article (PubMed ID: 12741592)
1. Transient erectile dysfunction associated with intramuscular injection of botulinum toxin type A.
Papadonikolakis AS; Vekris MD; Kostas JP; Korompilias AV; Soucacos PN
J South Orthop Assoc; 2002; 11(2):116-8. PubMed ID: 12741592
[TBL] [Abstract][Full Text] [Related]
2. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
3. Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction.
Akbar M; Abel R; Seyler TM; Bedke J; Haferkamp A; Gerner HJ; Möhring K
BJU Int; 2007 Sep; 100(3):639-45. PubMed ID: 17532858
[TBL] [Abstract][Full Text] [Related]
4. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot.
Mancini F; Sandrini G; Moglia A; Nappi G; Pacchetti C
Neurol Sci; 2005 Apr; 26(1):26-31. PubMed ID: 15877184
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin A injection for children with spastic cerebral palsy.
YaJie W; BaoQin G
Dev Med Child Neurol; 2008 Aug; 50(8):640. PubMed ID: 18754907
[No Abstract] [Full Text] [Related]
6. Ultrasound-guided submandibular gland injection of botulinum toxin for hypersalivation in cerebral palsy.
Sriskandan N; Moody A; Howlett DC
Br J Oral Maxillofac Surg; 2010 Jan; 48(1):58-60. PubMed ID: 19371986
[TBL] [Abstract][Full Text] [Related]
7. Comparing two types of botulinum-A toxin detrusor injections in patients with severe neurogenic detrusor overactivity: a case-control study.
Grosse J; Kramer G; Jakse G
BJU Int; 2009 Sep; 104(5):651-6. PubMed ID: 19281462
[TBL] [Abstract][Full Text] [Related]
8. Effect of botulinum toxin type A injection into human masseter muscle on stimulated parotid saliva flow rate.
Kwon JS; Kim ST; Jeon YM; Choi JH
Int J Oral Maxillofac Surg; 2009 Apr; 38(4):316-20. PubMed ID: 19231136
[TBL] [Abstract][Full Text] [Related]
9. [Botulinum toxin type A in the treatment plan for cerebral palsy].
Strobl W
Wien Klin Wochenschr; 2001; 113 Suppl 4():30-5. PubMed ID: 15506050
[TBL] [Abstract][Full Text] [Related]
10. [Persistent injury to an ocular motor muscle secondary to injection of botulinum toxin].
Gómez-Argüelles JM; Sebastián-de la Cruz F
Rev Neurol; 2008 Mar 1-15; 46(5):318-9. PubMed ID: 18351572
[No Abstract] [Full Text] [Related]
11. [Frequency of side effects after botulinum toxin A injections in neurology, rehabilitation and gastroenterology].
Sławek J; Madaliński MH; Maciag-Tymecka I; Duzyński W
Pol Merkur Lekarski; 2005 Mar; 18(105):298-302. PubMed ID: 15997637
[TBL] [Abstract][Full Text] [Related]
12. Repeated botulinum toxin injections can improve mobility in patients with spinal cord lesions.
Catz A; Barkol H; Steinberg F; Ronen J; Bluvshtein V; Keren O
Eura Medicophys; 2007 Sep; 43(3):319-25. PubMed ID: 17525702
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type a injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux.
Karsenty G; Elzayat E; Delapparent T; St-Denis B; Lemieux MC; Corcos J
J Urol; 2007 Mar; 177(3):1011-4. PubMed ID: 17296399
[TBL] [Abstract][Full Text] [Related]
14. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy.
Crowner BE; Racette BA
Pediatr Neurol; 2008 Oct; 39(4):253-8. PubMed ID: 18805363
[TBL] [Abstract][Full Text] [Related]
15. Relationship of botulinum dosage to duration of side effects and normal voice in adductor spasmodic dysphonia.
Chang CY; Chabot P; Thomas JP
Otolaryngol Head Neck Surg; 2007 Jun; 136(6):894-9. PubMed ID: 17547976
[TBL] [Abstract][Full Text] [Related]
16. Repeat injection of botulinum toxin A is safe and effective for upper limb movement and function in children with cerebral palsy.
Lowe K; Novak I; Cusick A
Dev Med Child Neurol; 2007 Nov; 49(11):823-9. PubMed ID: 17979860
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin-a in children with congenital spastic hemiplegia does not improve upper extremity motor-related function over rehabilitation alone: a randomized controlled trial.
Rameckers EA; Speth LA; Duysens J; Vles JS; Smits-Engelsman BC
Neurorehabil Neural Repair; 2009; 23(3):218-25. PubMed ID: 19106252
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin for cerebral palsy; where are we now?
Morton RE; Hankinson J; Nicholson J
Arch Dis Child; 2004 Dec; 89(12):1133-7. PubMed ID: 15557051
[TBL] [Abstract][Full Text] [Related]
19. [Neuromuscular blockade with botulinum toxin. From toxin to therapeutic agent].
Einecke D
MMW Fortschr Med; 2001 May; 143 Suppl 2():95-6. PubMed ID: 11434276
[No Abstract] [Full Text] [Related]
20. Comparison between intramuscular and perimuscular injections of botulinum toxin type A.
Campos JH; Oliveira LB; Queiroz TO; Santos KP; Freitas FM
Aesthetic Plast Surg; 2006; 30(6):700-3; discussion 704. PubMed ID: 16977369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]